4.7 Article

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

期刊

CELL HOST & MICROBE
卷 26, 期 5, 页码 623-+

出版社

CELL PRESS
DOI: 10.1016/j.chom.2019.09.016

关键词

-

资金

  1. Collaboration for AIDS Vaccine Discovery grants from the Bill and Melinda Gates Foundation [OPP1114725, OPP1032144]
  2. European Union [681137]
  3. FRISBI [ANR-10-INBS-05-02]
  4. GRAL, a project of the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS [ANR-17-EURE-0003]
  5. Institut Pasteur
  6. ANRS
  7. Vaccine Research Institute
  8. Gilead HIV cure program
  9. Bill and Melinda Gates Foundation [OPP1114725] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

Potent and broadly neutralizing antibodies (bnAbs) are the hallmark of HIV-1 protection by vaccination. The membrane-proximal external region (MPER) of the HIV-1 gp41 fusion protein is targeted by the most broadly reactive HIV-1 neutralizing antibodies. Here, we examine the structural and molecular mechansims of neutralization by anti-MPER bnAb, LN01, which was isolated from lymph-node-derived germinal center B cells of an elite controller and exhibits broad neutralization breadth. LN01 engages both MPER and the transmembrane (TM) region, which together form a continuous helix in complex with LN01. The tilted TM orientation allows LN01 to interact simultaneously with the peptidic component of the MPER epitope and membrane via two specific lipid binding sites of the antibody paratope. Although LN01 carries a high load of somatic mutations, most key residues interacting with the MPER epitope and lipids are germline encoded, lending support for the LN01 epitope as a candidate for lineage-based vaccine development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据